Sally Furniss
Well-known member
China's largest production base of the bird flu vaccine settled in Zhaoqing, Guangdong
At 19:44 on July 3, 2009 Source: China News Network
China news agency, Zhaoqing, July 3 (Huang Yaohui and Wang Juan) - Zhaoqing in Guangdong will become the production of biological medicines and veterinary drugs, bio-technology research and development, such as scientific research into bird flu vaccine production base. Guangdong Zhaoqing Huanong three major bio-pharmaceutical Co., Ltd. said that, after put into operation in August, the company will become China's largest production base of the bird flu vaccine.
The bird flu vaccine production base for three of the GMP workshop, five million U.S. dollars of investment, two complete H5N1 subtype of avian influenza inactivated vaccine production lines and laboratory animals rooms, covers an area of 40 acres.
Company introduced to the press, the project from the current domestic and foreign enterprises of advanced technology and mature equipment and manufacturing processes, equipment, a high degree of automation to reduce manual operations on the impact of product quality to ensure that each batch of heterogeneity, The annual production of the "avian flu vaccine" plume of three billion.
The company from Guangdong Wen's Group and co-founder of South China Agricultural University, after the company had five million U.S. dollars initial investment, annual production capacity of 1.5 billion bird flu vaccine plume were two additional investment of four million U.S. dollars, in September 2007 completed and put into production, annual production capacity of the avian flu vaccine plume of up to two billion.
Said, GMP after the completion of the three workshops, an annual output of avian influenza vaccine plume of up to 6.5 billion, annual production value of billion yuan RMB, China's largest production base of the bird flu vaccine, and planning the Phase IV expansion project.
http://www.chinanews.com.cn/jk/jk-ysbb/news/2009/07-03/1760614.shtml
At 19:44 on July 3, 2009 Source: China News Network
China news agency, Zhaoqing, July 3 (Huang Yaohui and Wang Juan) - Zhaoqing in Guangdong will become the production of biological medicines and veterinary drugs, bio-technology research and development, such as scientific research into bird flu vaccine production base. Guangdong Zhaoqing Huanong three major bio-pharmaceutical Co., Ltd. said that, after put into operation in August, the company will become China's largest production base of the bird flu vaccine.
The bird flu vaccine production base for three of the GMP workshop, five million U.S. dollars of investment, two complete H5N1 subtype of avian influenza inactivated vaccine production lines and laboratory animals rooms, covers an area of 40 acres.
Company introduced to the press, the project from the current domestic and foreign enterprises of advanced technology and mature equipment and manufacturing processes, equipment, a high degree of automation to reduce manual operations on the impact of product quality to ensure that each batch of heterogeneity, The annual production of the "avian flu vaccine" plume of three billion.
The company from Guangdong Wen's Group and co-founder of South China Agricultural University, after the company had five million U.S. dollars initial investment, annual production capacity of 1.5 billion bird flu vaccine plume were two additional investment of four million U.S. dollars, in September 2007 completed and put into production, annual production capacity of the avian flu vaccine plume of up to two billion.
Said, GMP after the completion of the three workshops, an annual output of avian influenza vaccine plume of up to 6.5 billion, annual production value of billion yuan RMB, China's largest production base of the bird flu vaccine, and planning the Phase IV expansion project.
http://www.chinanews.com.cn/jk/jk-ysbb/news/2009/07-03/1760614.shtml